GlassScriptPhysician profile
Scott Matthew Castle
NPI 1063702538
$4,105.98
in general payments reported to CMS, 2019-2025
33 companies · $1,138 in 2025
The $1,138 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $470 · 2021: $497 · 2022: $537 · 2023: $415 · 2024: $532 · 2025: $1,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,388 · Travel and Lodging: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,388.07 |
| Travel and Lodging | $696.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $842.82 | 2025 | |
| Boston Scientific Corporation | $496.18 | 2019-2025 | Axonics, Solyx Sis System, Bulkamid |
| Medtronic, INC. | $370.72 | 2021-2024 | Interstim |
| Neotract INC. | $327.00 | 2019-2020 | |
| Teleflex LLC | $301.97 | 2021-2024 | Urolift |
| Procept Biorobotics Corporation | $265.13 | 2019-2025 | Aquabeam System |
| Medtronic USA, INC. | $265.03 | 2019-2020 | |
| Axonics, INC. | $174.95 | 2021-2024 | Bulkamid |
| Astellas Pharma US INC | $117.69 | 2019-2023 | Myrbetriq |
| Myriad Genetic Laboratories, INC. | $88.82 | 2023 | Prolaris |
| Cook Medical LLC | $83.57 | 2024 | Zenith Spiral-Z |
| Olympus America INC. | $62.42 | 2022-2024 | Itind System, Cysto-Nephro Videoscope |
| Coloplast Corp | $58.66 | 2022-2024 | |
| Calyxo, INC. | $57.50 | 2024 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $57.10 | 2024-2025 | Gemtesa |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $55.43 | 2019-2022 | |
| 180 Medical, INC. | $53.73 | 2023-2024 | Cure Catheter |
| Dornier Medtech America, INC | $49.03 | 2024 | Dornier Medtech |
| Blue Earth Diagnostics | $48.63 | 2024-2025 | Posluma |
| Histosonics, INC. | $47.84 | 2025 | |
| Welch Allyn | $41.43 | 2019 | |
| Immunitybio, INC. | $28.56 | 2024 | |
| Ambu INC. | $25.85 | 2022 | |
| Angiodynamics, INC. | $25.43 | 2024 | Nanoknife |
| Tolmar Pharmaceuticals, INC. | $22.94 | 2022 | |
| Laborie Medical Technologies Corp. | $20.02 | 2023 | |
| Tolmar, INC. | $18.99 | 2025 | Eligard, Jatenzo |
| Allergan, INC. | $18.50 | 2019 | |
| Urovant Sciences INC | $17.31 | 2021 | |
| Endo Pharmaceuticals INC. | $17.19 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.97 | 2024 | Adstiladrin |
| Urogen Pharma, INC. | $16.75 | 2021 | |
| Valencia Technologies Corporation | $11.82 | 2023 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Castle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.